Latest News and Press Releases
Want to stay updated on the latest news?
-
CLEVELAND, OHIO, May 15, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed...
-
A CONFERENCE CALL IS SCHEDULED FOR MONDAY, MAY 18, 2026 11:00AM EASTERN TIME SEE DIAL IN NUMBER BELOW TABER, ALBERTA, May 15, 2026 (GLOBE NEWSWIRE) -- FLEXIBLE SOLUTIONS INTERNATIONAL, INC. (NYSE...
-
Haverford, PA, May 15, 2026 (GLOBE NEWSWIRE) -- Investview, Inc. (OTCQB: INVU) operates a diversified series of business units across key sectors, including a direct-to-consumer (“DTC”) marketing...
-
QIND Achieves Positive Net Income and Operating Income While Reducing Operating Expenses by Approximately 56.6% Year-Over-Year Al Shola Gas Awarded 16 New Engineering Subcontracts Subsequent to...
-
Agoura Hills, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a clinical-stage biotechnology company focused on oncology,...
-
Company Posts Best Q1 Fiscal Period in Its History with $2.1 Million in Revenue ROSEVILLE, MN, May 15, 2026 (GLOBE NEWSWIRE) -- SecureTech Innovations, Inc. (OTCQB: SCTH), a diversified technology...
-
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results
-
LAS VEGAS, May 15, 2026 (GLOBE NEWSWIRE) -- Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), an emerging provider of high-performance GPU infrastructure and AI cloud services, today announced...
-
Early blinded results show 40% composite complete remission rate across difficult-to-treat AML patient population in MIRACLE Trial First interim unblinding expected in June 2026 following 45 subject...
-
Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with additional updates anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE® in multiple solid tumor types known to express...